"Receptor, Endothelin B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.
| Descriptor ID |
D044023
|
| MeSH Number(s) |
D12.776.543.750.695.220.200 D12.776.543.750.750.320.200
|
| Concept/Terms |
Receptor, Endothelin B- Receptor, Endothelin B
- Endothelin B Receptor
- Endothelin B Receptors
- Receptors, Endothelin B
Receptor, Endothelin B, Type 2- Receptor, Endothelin B, Type 2
- Endothelin B-2 Receptors
- Endothelin B 2 Receptors
- Receptors, Endothelin B-2
- Endothelin B-2 Receptor
- Endothelin B 2 Receptor
- Receptor, Endothelin B-2
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Endothelin B".
Below are MeSH descriptors whose meaning is more specific than "Receptor, Endothelin B".
This graph shows the total number of publications written about "Receptor, Endothelin B" by people in this website by year, and whether "Receptor, Endothelin B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, Endothelin B" by people in Profiles.
-
Porphyromonas gingivalis infection upregulates the endothelin (ET) system in brain microvascular endothelial cells. Can J Physiol Pharmacol. 2022 Jul 01; 100(7):679-688.
-
Diabetes-related sex differences in the brain endothelin system following ischemia in vivo and in human brain endothelial cells in vitro. Can J Physiol Pharmacol. 2020 Sep; 98(9):587-595.
-
Endothelin and diabetic complications: a brain-centric view. Physiol Res. 2018 06 27; 67(Suppl 1):S83-S94.
-
Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells. Am J Pathol. 2017 Apr; 187(4):896-907.
-
Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control. Life Sci. 2014 Nov 24; 118(2):268-73.
-
Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes. Life Sci. 2014 Nov 24; 118(2):263-7.
-
G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis. J Biol Chem. 2012 Apr 06; 287(15):12309-20.
-
Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes. Neurol Res. 2011 Mar; 33(2):185-91.
-
Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. J Pharmacol Exp Ther. 2011 Apr; 337(1):9-15.
-
Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. Am J Physiol Gastrointest Liver Physiol. 2009 Jul; 297(1):G27-33.